Stem cells
Studying this course? Keep your progress in one place.
Key facts
- A stem cell divides by mitosis and can differentiate; potency is the range of cell types it can form.
- Totipotent cells form every cell type including the placenta; pluripotent cells form every body cell type but not the placenta; multipotent cells form a limited range.
- Potency is lost by epigenetic modification and transcription factors, not by losing genes.
- iPS cells are made by reprogramming differentiated cells and avoid destroying embryos or rejection.
What is a stem cell?
A stem cell is undifferentiated, can renew itself by mitosis and can differentiate; its potency is the range of cells it can form.
A stem cell is an undifferentiated cell that can divide by mitosis to make more stem cells (self-renewal) and can differentiate into specialised cells.
Stem cells are classified by their potency, the range of cell types they can form.
- Totipotent: every cell type, including extra-embryonic tissue such as the placenta (zygote, very early embryo).
- Pluripotent: every cell type of the body but not the placenta (inner cell mass of the blastocyst).
- Multipotent: a limited range of related cell types (e.g. haematopoietic stem cells in bone marrow).
- 1
Zygote: totipotent
every cell type, including the placenta
- 2
Inner cell mass: pluripotent
every body cell type, not the placenta
- 3
Adult stem cell: multipotent
a limited range of related cells, e.g. bone marrow
- 4
Specialised cell
differentiated
| Totipotent | Pluripotent | Multipotent | |
|---|---|---|---|
| Can form | Every cell type, including the placenta | Every body cell type, not the placenta | A limited range of related cell types |
| Found in | Zygote and very early embryo | Inner cell mass of the blastocyst | e.g. bone marrow |
Totipotent
- Can form:
- Every cell type, including the placenta
- Found in:
- Zygote and very early embryo
Pluripotent
- Can form:
- Every body cell type, not the placenta
- Found in:
- Inner cell mass of the blastocyst
Multipotent
- Can form:
- A limited range of related cell types
- Found in:
- e.g. bone marrow
Which cells can form every cell type including the placenta?
From zygote to differentiated cell
Every cell has the same genome; epigenetic modification and transcription factors silence genes, narrowing potency.
Every cell has the same genome, so loss of potency during development is caused by epigenetic modification and the action of transcription factors, not by loss of genes. The pattern of modification is passed on by mitosis.
In the pluripotent inner cell mass of the blastocyst, modifications such as DNA methylation, histone modification and non-coding RNA silence genes such as those for placental tissue. Further modification restricts cells to fewer types, until a differentiated cell expresses only the genes for one function.
- 1
Totipotent embryo cells
develop into a blastocyst
- 2
Pluripotent inner cell mass
epigenetic modifications silence genes for placental tissue
- 3
Multipotent cells
further modification restricts cells to a smaller range
- 4
Differentiated somatic cell
expresses only the genes for one function
Why does a differentiated cell lose potency?
Embryonic stem cells in medicine
Embryonic stem cells could replace damaged cells, but obtaining them destroys an embryo, raising ethical issues.
Pluripotent stem cells from embryos (usually spare IVF embryos at the blastocyst stage) can be grown and directed to form many cell types.
They offer new medical advances, for example replacement cells for spinal cord injury, diabetes (beta cells), heart disease or blindness, and models for testing drugs.
Examiners expect you to weigh both sides of an ethical consideration, not list only one.
- 1
Spare IVF embryo
grown to the blastocyst stage
- 2
Inner cell mass removed
this destroys the embryo
- 3
Pluripotent cells cultured
and directed to differentiate
- 4
Replacement cells
for example beta cells or spinal cord cells
Arguments for
- Spare IVF embryos would be discarded anyway
- The embryo is at a very early stage
- The benefit to patients is great
Arguments against
- Obtaining the cells destroys the embryo, a potential human life
- The embryo cannot give consent
- Cells differ genetically from the patient: risk of rejection
Which is an argument for using spare IVF embryos?
Induced pluripotent stem cells
iPS cells are made by reprogramming a differentiated cell with named genes, avoiding the destruction of embryos.
iPS cells are made by reprogramming a differentiated cell. Fibroblasts (connective tissue cells, easily taken from skin) are given named genes, such as Oct4, Sox2, Klf4 and c-Myc, often using a virus as a vector.
These genes code for transcription factors that switch on pluripotency genes and reverse the epigenetic modifications that had silenced them.
The cells are genetically identical to the patient, so there is less risk of rejection. Risks: c-Myc can cause cancer, viral vectors may disrupt other genes, and leftover undifferentiated cells can form tumours.
- 1
Take fibroblasts
easily taken from the patient's skin
- 2
Add Oct4, Sox2, Klf4 and c-Myc
often using a virus as a vector
- 3
Reprogrammed iPS cells
pluripotent; no embryo destroyed
- 4
Differentiate
genetically identical to the patient, but with a tumour risk
| Embryonic stem cells | iPS cells | |
|---|---|---|
| Issue | Destroys an embryo | No embryo destroyed |
| Consequence | Genetically different from patient: rejection risk | Genetically identical to patient; tumour risk |
Embryonic stem cells
- Issue:
- Destroys an embryo
- Consequence:
- Genetically different from patient: rejection risk
iPS cells
- Issue:
- No embryo destroyed
- Consequence:
- Genetically identical to patient; tumour risk
What is used to make a fibroblast pluripotent?
Try an exam question
Explain why induced pluripotent stem (iPS) cells may be preferred to embryonic stem cells for treating a patient.
[4 marks]
- [1]iPS cells are made from the patient's own differentiated cells, so no embryo is destroyed.
- [1]This avoids the ethical objections to using embryos.
- [1]They are genetically identical to the patient, so there is less risk of rejection.
- [1]No immunosuppressant drugs are needed.
That's the notes covered.
Carry on to the next subtopic.
Try a question
Which term describes the haematopoietic stem cells in the bone marrow?
1 mark, marked against the mark scheme
Which term describes the haematopoietic stem cells in the bone marrow?
1 mark, marked against the mark scheme